• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌组分的免疫调节作用。

Immunomodulation by bacterial fractions.

作者信息

Barot-Ciorbaru R

机构信息

C.N.R.S. URA 1116, Immunomodulateurs de Nocardiae, Université Paris-Sud, Orsay, France.

出版信息

Int J Immunopharmacol. 1994 May-Jun;16(5-6):469-73. doi: 10.1016/0192-0561(94)90038-8.

DOI:10.1016/0192-0561(94)90038-8
PMID:7927995
Abstract

The cells of Nocardia opaca are a source of potent immunostimulating substances, differing in solubility and in the presence or absence of peptidoglycan. Three classes of N. opaca fractions have been investigated: (1) NDCM (Nocardia delipidated cell mitogen), the starting fraction; (2) PG (peptidoglycan)-containing fractions: CW (cell walls), PG, and fractions containing soluble PG derivatives such as NWSM (Nocardia water soluble mitogen) and NSPD (Nocardia soluble peptidoglycan derivative); and (3) soluble fractions devoid of PG, such as NWSMP (NWSP-pellet) and CyI (cytoplasmic membrane). This report summarizes our results on the relationship between the structure of N. opaca fractions and their stimulatory activities on mouse, rabbit, germ-free piglet and human lymphocytes and monocytes/macrophages. The studies of biological properties of these compounds are the result of an extensive collaborative effort of several teams.

摘要

不透明诺卡氏菌的细胞是强效免疫刺激物质的来源,这些物质在溶解度以及是否存在肽聚糖方面存在差异。已对不透明诺卡氏菌的三类组分进行了研究:(1)NDCM(脱脂诺卡氏菌细胞促细胞分裂剂),起始组分;(2)含PG(肽聚糖)的组分:CW(细胞壁)、PG,以及含有可溶性PG衍生物的组分,如NWSM(诺卡氏菌水溶性促细胞分裂剂)和NSPD(诺卡氏菌可溶性肽聚糖衍生物);(3)不含PG的可溶性组分,如NWSMP(NWSP沉淀)和CyI(细胞质膜)。本报告总结了我们关于不透明诺卡氏菌组分的结构与其对小鼠、兔子、无菌仔猪及人淋巴细胞和单核细胞/巨噬细胞的刺激活性之间关系的研究结果。这些化合物生物学特性的研究是多个团队广泛合作的成果。

相似文献

1
Immunomodulation by bacterial fractions.细菌组分的免疫调节作用。
Int J Immunopharmacol. 1994 May-Jun;16(5-6):469-73. doi: 10.1016/0192-0561(94)90038-8.
2
Stimulation of human B lymphocytes by Nocardia-delipidated cell mitogen and derived fractions from N. opaca. Structure-activity relationship.用诺卡氏菌脱脂细胞促细胞分裂剂和不透明诺卡氏菌的衍生组分刺激人B淋巴细胞。构效关系。
J Immunol. 1985 Nov;135(5):3277-83.
3
Enhancement of natural killer cell activity by Nocardia opaca fractions.不透明诺卡氏菌组分增强自然杀伤细胞活性
Scand J Immunol. 1989 Feb;29(2):133-41. doi: 10.1111/j.1365-3083.1989.tb01109.x.
4
Antimetastatic effect of immunomodulators from Nocardia opaca in mice and rats activation of peritoneal macrophages by these fractions.诺卡氏菌免疫调节剂对小鼠和大鼠的抗转移作用:这些组分激活腹膜巨噬细胞。
Cancer Immunol Immunother. 1987;25(2):111-8. doi: 10.1007/BF00199950.
5
Stimulation of sea star Asterias rubens axial organ B-like cells by Nocardia-delipidated cell mitogen and derived fractions.诺卡氏菌脱脂细胞促细胞分裂原及其衍生组分对海星红斑海盘车轴器官B样细胞的刺激作用。
Folia Biol (Praha). 1988;34(3):182-91.
6
Nocardia fractions, NLD and NWSM, induce tumor necrosis factor-alpha secretion in human monocytes: role of protein kinase C.诺卡氏菌组分NLD和NWSM可诱导人单核细胞分泌肿瘤坏死因子-α:蛋白激酶C的作用
Eur J Immunol. 1993 Jul;23(7):1582-7. doi: 10.1002/eji.1830230728.
7
Induction of interferon synthesis in mice by fractions from Nocardia.诺卡氏菌提取物诱导小鼠体内干扰素的合成
Infect Immun. 1978 Feb;19(2):353-6. doi: 10.1128/iai.19.2.353-356.1978.
8
Stimulation of enterocyte enzymatic activities, MHC class II expression and other immunological factors after oral treatment with Nocardia delipidated cell mitogen in germ-free rats.在无菌大鼠中,用脱脂诺卡氏菌细胞促细胞分裂剂进行口服治疗后,对肠细胞酶活性、MHC II类表达及其他免疫因子的刺激作用。
Int J Immunopharmacol. 1994 May-Jun;16(5-6):487-93. doi: 10.1016/0192-0561(94)90041-8.
9
Nocardia water soluble mitogen (NWSM), a human B-lymphocyte mitogen.诺卡氏菌水溶性促细胞分裂剂(NWSM),一种人类B淋巴细胞促细胞分裂剂。
Int J Immunopharmacol. 1986;8(8):943-9. doi: 10.1016/0192-0561(86)90096-2.
10
Antitumoral activity of an immunomodulatory fraction of Nocardia opaca: mechanism of action.不透明诺卡氏菌免疫调节组分的抗肿瘤活性:作用机制
Int J Immunopharmacol. 1994 May-Jun;16(5-6):475-80. doi: 10.1016/0192-0561(94)90039-6.